Label-free Array Systems Market Size, Share & Trends Analysis Report By Type (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
Heading: Massage Equipment Market Growth & Trends
The global massage equipment market size is expected to reach USD 18.84 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.8% from 2025 to 2030. Growing importance of healthy lifestyle among all age groups at the global level as a result of extensive brand campaigns aimed at maintaining fit body is projected to expand the scope for massage equipment. Additionally, hectic workstyle due to excess of 8 to 9 hours of desk jobs among working class professionals has led to increase in the occurrence of constant pain in the neck, shoulder, knee, and hip joints. Light massage at a certain interval can help the common mass overcome these issues and lead a healthy life. Thus, the corporate organizations and multi-national firms started installing massage chairs, sofas, and other equipment to resolve the everyday issues and ensure quick relaxation.
Arthritis has evolved as one of the most common ailments across the world. Affected patients suffer from swelling, tenderness, stiffness, and joint pain, which typically worsens with age. As of 2019, it was observed that around 350 million people worldwide suffer from arthritis, where 40 million patients are located in U.S. More than a quarter million of these patients were kids and 60% of the total patients in U.S. were females. Massage through various techniques can provide a huge relief to incessant pain. Neuroscientists have noticed that massage helps in activating those parts of brain, which are triggered under the influence of opioid painkillers such as codeine.
Some of the key massage equipment market players are OSIM International Ltd.; JSB Healthcare; Panasonic; Prospera; Casada International; RoboTouch; and Prospera. Product innovation is expected to remain a key success factor for the market participants over the next few years. For instance, in September 2019, Acer launched Thronos Air Gaming Throne, which has massaging functionalities embedded in the seat and can rub the back, when required. The gaming chair massages the back only as the backrest includes two balls, which move up and down against the back, giving it a relaxing feeling. The product is available for USD 9000.
Massage Equipment Market Report Highlights
- By product, chairs and sofas held over 51.8% share in 2024 due to predominant use of such equipment in commercial spaces. Handheld massagers are expected to expand at the fastest CAGR of 9.7% from 2025 to 2030 as they provide convenience to the buyers
- The home application segment is expected to expand at the fastest CAGR from 2025 to 2030 due to shifting inclination towards a healthy lifestyle among millennials and increasing use of such type of equipment in home
- North America led the massage equipment market and accounted for a share of 39.8% in 2024 on account of high concentration of health enthusiasts in U.S. and Canada
- New launches in terms of inclusion of smart features is expected to remain a key strategy among the market participants.
- Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.5. Market Restraint Analysis
- 3.6. Penetration and Growth Prospect Mapping 2022
- 3.7. Business Environment Analysis
- 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.7.2. Porter’s Five Forces Analysis
- 3.8. COVID-19 Impact Analysis
- Chapter 4. Type Business Analysis
- 4.1. Label-free Array Systems Market: Type Movement Analysis
- 4.2. Surface Plasmon Resonance
- 4.2.1. Surface Plasmon Resonance Market, 2018 - 2030 (USD Million)
- 4.3. Bio-layer Interferometry
- 4.3.1. Bio-layer Interferometry Market, 2018 - 2030 (USD Million)
- 4.4. Cellular Dielectric Spectroscopy
- 4.4.1. Cellular Dielectric Spectroscopy Market, 2018 - 2030 (USD Million)
- Chapter 5. Application Business Analysis
- 5.1. Label-free Array Systems Market: Application Movement Analysis
- 5.2. Drug Discovery
- 5.2.1. Drug Discovery Market, 2018 - 2030 (USD Million)
- 5.3. Protein Interface Analysis
- 5.3.1. Protein Interface Analysis Market, 2018 - 2030 (USD Million)
- 5.4. Antibody Characterization
- 5.4.1. Antibody Characterization Market, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 6. End-use Business Analysis
- 6.1. Label-free Array Systems Market: End-use Movement Analysis
- 6.2. Pharmaceutical & Biotechnology Companies
- 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
- 6.3. Academic & Research Institutes
- 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
- 6.4. CRO
- 6.4.1. CRO Market, 2018 - 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others Market, 2018 - 2030 (USD Million)
- Chapter 7. Regional Business Analysis
- 7.1. Label-free Array Systems Market Share By Region, 2024 & 2030
- 7.2. North America
- 7.2.1. SWOT Analysis
- 7.2.2. North America Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.2.3. U.S.
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Scenario
- 7.2.3.6. U.S. Label-free array systems Market, 2018 - 2030 (USD MILLION)
- 7.2.4. Canada
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Target Disease Prevalence
- 7.2.4.3. Competitive Scenario
- 7.2.4.4. Regulatory Framework
- 7.2.4.5. Reimbursement Scenario
- 7.2.4.6. Canada Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.2.5. Mexico
- 7.2.5.1. Key Country Dynamics
- 7.2.5.2. Target Disease Prevalence
- 7.2.5.3. Competitive Scenario
- 7.2.5.4. Regulatory Framework
- 7.2.5.5. Reimbursement Scenario
- 7.2.5.6. Mexico Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. SWOT Analysis
- 7.3.2. Europe Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Scenario
- 7.3.3.6. Germany Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.4. UK
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Scenario
- 7.3.4.6. UK Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.5. France
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Scenario
- 7.3.5.6. France Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.6. Italy
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Scenario
- 7.3.6.6. Italy Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.7. Spain
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Spain Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.8. Denmark
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Scenario
- 7.3.8.6. Denmark Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.9. Sweden
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Scenario
- 7.3.9.6. Sweden Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.3.10. Norway
- 7.3.10.1. Key Country Dynamics
- 7.3.10.2. Target Disease Prevalence
- 7.3.10.3. Competitive Scenario
- 7.3.10.4. Regulatory Framework
- 7.3.10.5. Reimbursement Scenario
- 7.3.10.6. Norway Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. SWOT Analysis
- 7.4.2. Asia Pacific Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Scenario
- 7.4.3.6. Japan Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.4. China
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Scenario
- 7.4.4.6. China Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.5. India
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Scenario
- 7.4.5.6. India Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. South Korea Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.7. Australia
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Scenario
- 7.4.7.6. Australia Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.4.8. Thailand
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Target Disease Prevalence
- 7.4.8.3. Competitive Scenario
- 7.4.8.4. Regulatory Framework
- 7.4.8.5. Reimbursement Scenario
- 7.4.8.6. Thailand Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. SWOT Analysis
- 7.5.2. Latin America Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.5.3. Brazil
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Scenario
- 7.5.3.6. Brazil Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Regulatory Framework
- 7.5.4.5. Reimbursement Scenario
- 7.5.4.6. Argentina Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.6. MEA
- 7.6.1. SWOT Analysis
- 7.6.2. MEA Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.6.3. South Africa
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Scenario
- 7.6.3.6. South Africa Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.6.4. Saudi Arabia
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Scenario
- 7.6.4.6. Saudi Arabia Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.6.5. UAE
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Scenario
- 7.6.5.6. UAE Label-free array systems Market, 2018 - 2030 (USD Million)
- 7.6.6. Kuwait
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Target Disease Prevalence
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Regulatory Framework
- 7.6.6.5. Reimbursement Scenario
- 7.6.6.6. Kuwait Label-free array systems Market, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Share Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Illumina, Inc.,
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.1.3. Collection Site Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.2.3. Collection Site Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Agilent Technologies, Inc.
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.3.3. Collection Site Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. PerkinElmer, Inc.
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.4.3. Collection Site Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Merck KGaA
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.5.3. Collection Site Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Danaher Corporation
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.6.3. Collection Site Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Bio-Rad Laboratories, Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.7.3. Collection Site Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. F. Hoffmann-La Roche AG
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.8.3. Collection Site Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Becton, Dickinson and Company
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.9.3. Collection Site Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Sartorius AG.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.10.3. Collection Site Benchmarking
- 8.4.10.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook